- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.2: 9 residues within 4Å:- Chain A: G.153, R.156, T.157, L.202, W.206, L.488, Y.489, A.490, L.506
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:W.206
PEG.10: 7 residues within 4Å:- Chain B: G.153, R.156, T.157, L.202, W.206, L.488, A.490
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:W.206
PEG.18: 9 residues within 4Å:- Chain C: G.153, R.156, T.157, L.202, W.206, L.488, Y.489, A.490, L.506
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.157, C:W.206
PEG.26: 7 residues within 4Å:- Chain D: G.153, R.156, T.157, L.202, W.206, L.488, A.490
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:T.157, D:W.206
- 18 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 6 residues within 4Å:- Chain A: K.283, R.293, V.294
- Chain B: K.283, V.294, N.502
Ligand excluded by PLIPGOL.4: 3 residues within 4Å:- Chain A: K.356, C.398, G.399
Ligand excluded by PLIPGOL.6: 7 residues within 4Å:- Chain A: L.111, H.118, D.166, K.167
- Chain D: H.118, R.159, Y.160
Ligand excluded by PLIPGOL.7: 7 residues within 4Å:- Chain A: I.168, G.170, R.184, H.185
- Chain C: T.172, I.173, P.174
Ligand excluded by PLIPGOL.8: 4 residues within 4Å:- Chain A: E.508, Y.509
- Chain B: K.171, H.185
Ligand excluded by PLIPGOL.11: 5 residues within 4Å:- Chain B: A.310, D.311, L.312, D.313, R.350
Ligand excluded by PLIPGOL.12: 5 residues within 4Å:- Chain B: K.47, F.48, T.49, K.50, W.57
Ligand excluded by PLIPGOL.15: 8 residues within 4Å:- Chain B: T.172, I.173, P.174
- Chain D: I.168, Q.169, G.170, R.184, H.185
Ligand excluded by PLIPGOL.16: 3 residues within 4Å:- Chain B: Q.76, C.78, E.79
Ligand excluded by PLIPGOL.19: 6 residues within 4Å:- Chain C: K.283, R.293, V.294
- Chain D: K.283, V.294, N.502
Ligand excluded by PLIPGOL.20: 3 residues within 4Å:- Chain C: K.356, C.398, G.399
Ligand excluded by PLIPGOL.22: 7 residues within 4Å:- Chain B: H.118, R.159, Y.160
- Chain C: L.111, H.118, D.166, K.167
Ligand excluded by PLIPGOL.23: 7 residues within 4Å:- Chain A: T.172, I.173, P.174
- Chain C: I.168, G.170, R.184, H.185
Ligand excluded by PLIPGOL.24: 4 residues within 4Å:- Chain C: E.508, Y.509
- Chain D: K.171, H.185
Ligand excluded by PLIPGOL.27: 5 residues within 4Å:- Chain D: A.310, D.311, L.312, D.313, R.350
Ligand excluded by PLIPGOL.28: 5 residues within 4Å:- Chain D: K.47, F.48, T.49, K.50, W.57
Ligand excluded by PLIPGOL.31: 8 residues within 4Å:- Chain B: I.168, Q.169, G.170, R.184, H.185
- Chain D: T.172, I.173, P.174
Ligand excluded by PLIPGOL.32: 3 residues within 4Å:- Chain D: Q.76, C.78, E.79
Ligand excluded by PLIP- 4 x P4C: O-ACETALDEHYDYL-HEXAETHYLENE GLYCOL(Non-covalent)
P4C.5: 13 residues within 4Å:- Chain A: I.149, F.199, M.203, W.206, Q.321, F.325, C.330, C.331, Y.485, N.486, L.488, F.494
- Ligands: NAD.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.486
P4C.13: 8 residues within 4Å:- Chain B: I.149, F.199, F.325, C.330, C.331, N.486, L.488
- Ligands: NAD.9
1 PLIP interactions:1 interactions with chain B- Water bridges: B:N.486
P4C.21: 13 residues within 4Å:- Chain C: I.149, F.199, M.203, W.206, Q.321, F.325, C.330, C.331, Y.485, N.486, L.488, F.494
- Ligands: NAD.17
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.486
P4C.29: 8 residues within 4Å:- Chain D: I.149, F.199, F.325, C.330, C.331, N.486, L.488
- Ligands: NAD.25
1 PLIP interactions:1 interactions with chain D- Water bridges: D:N.486
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.14: 4 residues within 4Å:- Chain B: R.106, R.184, E.186, P.187
5 PLIP interactions:5 interactions with chain B- Water bridges: B:R.106, B:R.184, B:R.184
- Salt bridges: B:R.106, B:R.184
SO4.30: 4 residues within 4Å:- Chain D: R.106, R.184, E.186, P.187
5 PLIP interactions:5 interactions with chain D- Water bridges: D:R.106, D:R.184, D:R.184
- Salt bridges: D:R.106, D:R.184
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Castellvi, A. et al., Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3. Commun Biol (2022)
- Release Date
- 2022-04-20
- Peptides
- Aldehyde dehydrogenase family 1 member A3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 18 x GOL: GLYCEROL(Non-functional Binders)
- 4 x P4C: O-ACETALDEHYDYL-HEXAETHYLENE GLYCOL(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Castellvi, A. et al., Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3. Commun Biol (2022)
- Release Date
- 2022-04-20
- Peptides
- Aldehyde dehydrogenase family 1 member A3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B